Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

PROSTAID Calgary's 2022 Pathfinder Award went to Dr. Geoffrey Gotto, clinical oncologist at the Southern Alberta Institute of Urology. Dr. Gotto was gracious enough to give us a presentation afterward on new research and innovations in metastatic castration-sensitive prostate cancer (MCSPC) that is leading to longer survival and greater quality of life in prostate cancer patients who do combinations of treatments to combat the cancer.